Jefferies (NYSE:JEF) analyst Stephanie Wissink maintained a Buy rating on Nu Skin Enterprises on Tuesday, setting a price target of $66, which is approximately 24.76% above the present share price of $52.9.
Wissink expects Nu Skin Enterprises to post earnings per share (EPS) of $1.42 for the second quarter of 2021.
The current consensus among 3 TipRanks analysts is for a Moderate Buy rating of shares in Nu Skin, with an average price target of $63.
The analysts price targets range from a high of $66 to a low of $58.
In its latest earnings report, released on 12/31/2020, the company reported a quarterly revenue of $748.19 million and a net profit of $88.7 million. The company's market cap is $2.69 billion.
According to TipRanks.com, Jefferies analyst Stephanie Wissink is currently ranked with 4 stars on a 0-5 stars ranking scale, with an average return of 5.0% and a 54.44% success rate.
Nu Skin Enterprises, Inc. develops and distributes personal care products and nutritional supplements. The firm engages in the provision of beauty and wellness products and solutions. Its brands include Nu Skin and Pharmanex. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.